Valiant Laboratories Ltd.

VALIANTLAB

₹89.96

0.91% (0.81)

Market Cap

₹485 Cr.

P/E

0.00

About

Valiant Laboratories is in the Pharmaceuticals sector with a M.cap of 485.00 Cr and a PE ratio of 0.0.

Valiant Laboratories is in the Pharmaceuticals sector with a M.cap of 485.00 Cr and a … Read more

Low

52W Range

High

124

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

5 Yes

Positive for this company

3 Neutral

Neutral for this company

5 No

Negative for this company

4 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Other Income

Other income component is making ratios of the company look optically better

Price & Performance

Working Capital

Working capital of the company seems to be under control
Capex vs ROCE

Company has made significant capex which might be affecting its roce
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Share price

Share price has decreased over last 10 years more due to earnings
Debt

Company might have issues servicing its debt
ROE

Roe has decreased vs 10 year trend
Current vs Historic Valuation

Unable to calculate due to limited data
Sales Growth

Unable to calculate due to limited data
Margin Stability

Unable to calculate due to limited data
ROCE Strength

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Asset Break-Up - Geography Wise

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Valiant Laboratories Ltd. Business

What does Valiant Laboratories do?

Who are the competitors of Valiant Laboratories?

Valiant Laboratories major competitors are Medicamen Biotech, Fredun Pharma, Albert David, Jenburkt Pharma, Brooks Laboratories, Chandan Healthcare, Zim Laboratories.
Market Cap of Valiant Laboratories is ₹485 Crs.
While the median market cap of its peers are ₹481 Crs.

Is Valiant Laboratories financially stable compared to its competitors?

Valiant Laboratories seems to be less financially stable compared to its competitors.
Altman Z score of Valiant Laboratories is 4.56 and is ranked 5 out of its 8 competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Valiant Laboratories Ltd.